Vera Therapeutics Inc.

NASDAQ: VERA · Real-Time Price · USD
21.55
0.28 (1.32%)
At close: Aug 15, 2025, 3:59 PM
21.21
-1.58%
After-hours: Aug 15, 2025, 07:17 PM EDT

Vera Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
563K n/a n/a n/a n/a -952K -635K n/a n/a -506K n/a n/a n/a 9K 32K 59K 50K 35K
Gross Profit
-563K n/a n/a n/a n/a 952K 635K n/a n/a 506K n/a n/a n/a -9K -32K -59K -50K -35K
Operating Income
-80.14M -57.19M -48.91M -49.8M -37.34M -31.11M -27.03M -21.76M -21.97M -31.26M -33.58M -25.24M -15.06M -17.02M -16.59M -7.25M -5.85M -4.72M
Interest Income
6.32M 6.91M 6.66M 4.76M 5.1M 4.19M 1.96M 2.16M 2.24M 1.62M 894K 567K 263K 26K 6K 5K 2K 2K
Pretax Income
-76.53M -51.69M -43.42M -46.63M -33.71M -28.38M -25.65M -20.1M -20.16M -30.07M -32.44M -24.68M -14.85M -17.09M -16.85M -7.61M -3.44M -4.71M
Net Income
-76.53M -51.69M -43.42M -46.63M -33.71M -28.38M -25.66M -20.1M -20.16M -29.75M -32.44M -24.11M -14.85M -17.15M -16.85M -7.61M -3.44M -4.71M
Selling & General & Admin
21.5M 15.92M 15.57M 9.49M 8.03M 7.39M 5.71M 5.66M 5.74M 6.15M 6.91M 5.59M 4.95M 4.47M 3.83M 3.69M 2.61M 1.78M
Research & Development
58.08M 41.28M 33.35M 40.31M 29.31M 24.67M 21.95M 16.1M 16.23M 25.11M 26.68M 19.66M 10.11M 12.55M 12.75M 3.56M 3.23M 2.93M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.19M n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
79.58M 57.19M 48.91M 49.8M 37.34M 32.06M 27.66M 21.76M 21.97M 31.26M 33.58M 25.24M 15.06M 17.02M 16.59M 7.25M 5.85M 4.72M
Interest Expense
1.87M 1.79M 1.87M 1.94M 1.91M 1.91M 1.06M 943K 914K 874K 599K 147K 128K 118K 20K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -517K -532K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
80.14M 57.19M 48.91M 49.8M 37.34M 31.11M 27.03M 21.76M 21.97M 31.26M 33.58M 25.24M 15.06M 17.02M 16.59M 7.25M 5.85M 4.72M
Income Tax Expense
n/a n/a 1K n/a n/a n/a 1K n/a n/a -315K 1K -565K n/a 64K 1K n/a n/a -2K
Shares Outstanding (Basic)
63.79M 63.67M 54.9M 54.9M 54.73M 50.97M 44.45M 44.36M 44.27M 37.67M 27.8M 27.22M 27.08M 24.23M 21.28M 21.27M 20.87M 20.48M
Shares Outstanding (Diluted)
63.79M 63.67M 54.9M 54.9M 54.73M 50.97M 44.45M 44.36M 44.27M 37.67M 27.8M 27.22M 27.08M 24.23M 21.28M 21.27M 20.87M 20.48M
EPS (Basic)
-1.2 -0.81 -0.85 -0.85 -0.62 -0.56 -0.58 -0.45 -0.46 -0.79 -1.17 -0.89 -0.55 -0.71 -0.79 -0.36 -0.16 -0.23
EPS (Diluted)
-1.2 -0.81 -0.85 -0.85 -0.62 -0.56 -0.58 -0.45 -0.46 -0.79 -1.17 -0.89 -0.55 -0.71 -0.79 -0.36 -0.16 -0.23
EBITDA
-74.09M -57.19M -41.5M -44.67M -31.8M -27.43M -27.16M -21.76M -19.25M -29.7M -31.84M -25.24M -15.06M -16.96M -16.79M -7.55M -3.39M -4.68M
EBIT
-74.66M -57.19M -41.55M -44.7M -31.8M -26.48M -26.53M -19.16M -19.25M -29.2M -31.84M -24.53M -14.72M -16.97M -16.83M -7.61M -3.44M -4.71M
Depreciation & Amortization
563K 85K 55K 24K 1.5M -952K -635K -1.44M -971K -506K -597K -152K -106K 9K 32K 59K 50K 35K